Walley AJ, Blakemore AI, Froguel P. Genetics of obesity and the prediction of risk for health. „Hum. Mol. Genet.”. 15 Spec No 2, s. R124-30, 2006. DOI: 10.1093/hmg/ddl215. PMID: 16987875.
Barrett TG. Mitochondrial diabetes, DIDMOAD and other inherited diabetes syndromes. „Best Pract. Res. Clin. Endocrinol. Metab.”. 15 (3), s. 325-43, 2001. DOI: 10.1053/beem.2001.0149. PMID: 11554774.
Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson J, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle T, Uusitupa M, Tuomilehto J. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.. „Lancet”. 368 (9548), s. 1673–9, 2006. DOI: 10.1016/S0140-6736(06)69701-8. PMID: 17098085.
Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E, Nathan D. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.. „N Engl J Med”. 346 (6), s. 393–403, 2002. DOI: 10.1056/NEJMoa012512. PMID: 11832527. PMCID: PMC1370926.
Gerstein H, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman R. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. „Lancet”. 368 (9541), s. 1096–105, 2006. DOI: 10.1016/S0140-6736(06)69420-8. PMID: 16997664.
Kjeldsen SE, Julius S, Mancia G, McInnes GT, Hua T, Weber MA, Coca A, Ekman S, Girerd X, Jamerson K, Larochelle P, Macdonald TM, Schmieder RE, Schork MA, Stolt P, Viskoper R, Widimsky J, Zanchetti A; for the VALUE Trial Investigators. Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.. „J Hypertens”. 24 (7), s. 1405–1412, 2006. DOI: 10.1097/01.hjh.0000234122.55895.5b. PMID: 16794491.
Wasko MC, Hubert HB, Lingala VB, et al. Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. „JAMA”. 298 (2), s. 187-93, 2007. DOI: 10.1001/jama.298.2.187. PMID: 17622600.
Stuebe AM, Rich-Edwards JW, Willett WC, Manson JE, Michels KB. Duration of lactation and incidence of type 2 diabetes. „JAMA”. 294 (20), s. 2601–10, 2005. DOI: 10.1001/jama.294.20.2601. PMID: 16304074.
V. Chatsudthipong, C. Muanprasat. Stevioside and related compounds: therapeutic benefits beyond sweetness.. „Pharmacol Ther”. 121 (1), s. 41-54, Jan 2009. DOI: 10.1016/j.pharmthera.2008.09.007. PMID: 19000919.
Maurice J. O'Kane, Brendan Bunting, Margaret Copeland, Vivien E. Coates i inni. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial.. „BMJ”. 336 (7654), s. 1174-1177, May 2008. DOI: 10.1136/bmj.39534.571644.BE. PMID: 18420662. PMCID: PMC2394643.
dx.doi.org
ChristianCh.BommerChristianCh. i inni, The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study, „The Lancet Diabetes & Endocrinology”, 2017, DOI: 10.1016/S2213-8587(17)30097-9.
Walley AJ, Blakemore AI, Froguel P. Genetics of obesity and the prediction of risk for health. „Hum. Mol. Genet.”. 15 Spec No 2, s. R124-30, 2006. DOI: 10.1093/hmg/ddl215. PMID: 16987875.
Barrett TG. Mitochondrial diabetes, DIDMOAD and other inherited diabetes syndromes. „Best Pract. Res. Clin. Endocrinol. Metab.”. 15 (3), s. 325-43, 2001. DOI: 10.1053/beem.2001.0149. PMID: 11554774.
Borch-Johnsen K, Joner G, Mandrup-Poulsen T, Christy M, Zachau-Christiansen B, Kastrup K, Nerup J. Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. A hypothesis. „Lancet”. 2 (8411), s. 1083-6, 1984. PMID: 6150150.
Virtanen S, Knip M. Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age. „Am J Clin Nutr”. 78 (6), s. 1053-67, 2003. PMID: 14668264.
Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson J, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle T, Uusitupa M, Tuomilehto J. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.. „Lancet”. 368 (9548), s. 1673–9, 2006. DOI: 10.1016/S0140-6736(06)69701-8. PMID: 17098085.
Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E, Nathan D. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.. „N Engl J Med”. 346 (6), s. 393–403, 2002. DOI: 10.1056/NEJMoa012512. PMID: 11832527. PMCID: PMC1370926.
Gerstein H, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman R. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. „Lancet”. 368 (9541), s. 1096–105, 2006. DOI: 10.1016/S0140-6736(06)69420-8. PMID: 16997664.
Kjeldsen SE, Julius S, Mancia G, McInnes GT, Hua T, Weber MA, Coca A, Ekman S, Girerd X, Jamerson K, Larochelle P, Macdonald TM, Schmieder RE, Schork MA, Stolt P, Viskoper R, Widimsky J, Zanchetti A; for the VALUE Trial Investigators. Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.. „J Hypertens”. 24 (7), s. 1405–1412, 2006. DOI: 10.1097/01.hjh.0000234122.55895.5b. PMID: 16794491.
Wasko MC, Hubert HB, Lingala VB, et al. Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. „JAMA”. 298 (2), s. 187-93, 2007. DOI: 10.1001/jama.298.2.187. PMID: 17622600.
Stuebe AM, Rich-Edwards JW, Willett WC, Manson JE, Michels KB. Duration of lactation and incidence of type 2 diabetes. „JAMA”. 294 (20), s. 2601–10, 2005. DOI: 10.1001/jama.294.20.2601. PMID: 16304074.
R. Abudula, PB. Jeppesen, SE. Rolfsen, J. Xiao i inni. Rebaudioside A potently stimulates insulin secretion from isolated mouse islets: studies on the dose-, glucose-, and calcium-dependency.. „Metabolism”. 53 (10), s. 1378-81, Oct 2004. PMID: 15375798.
PB. Jeppesen, S. Gregersen, CR. Poulsen, K. Hermansen. Stevioside acts directly on pancreatic beta cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity.. „Metabolism”. 49 (2), s. 208-14, Feb 2000. PMID: 10690946.
V. Chatsudthipong, C. Muanprasat. Stevioside and related compounds: therapeutic benefits beyond sweetness.. „Pharmacol Ther”. 121 (1), s. 41-54, Jan 2009. DOI: 10.1016/j.pharmthera.2008.09.007. PMID: 19000919.
Maurice J. O'Kane, Brendan Bunting, Margaret Copeland, Vivien E. Coates i inni. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial.. „BMJ”. 336 (7654), s. 1174-1177, May 2008. DOI: 10.1136/bmj.39534.571644.BE. PMID: 18420662. PMCID: PMC2394643.